Zobrazeno 1 - 10
of 382
pro vyhledávání: ''
Autor:
Raj Singh, Nicholas G. Zaorsky, Joshua D. Palmer, Daniel M. Trifiletti, H.K. Perlow, Ming Wang, Eric J. Lehrer, Silvia Scoccianti, Vinai Gondi, Paul D. Brown, Pierina Navarria, Joseph Bovi
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 111:371-384
Purpose Limited evidence is available on the utility of dose-escalated radiation therapy (DE-RT) with or without temozolomide (TMZ) versus standard-of-care radiation therapy (SoC-RT) for patients with newly diagnosed glioblastoma multiforme. We perfo
Autor:
Sophie Bockel, Emmanuelle Gallois, Samy Ammari, Roger Sun, Sofia Rivera, Alberto Bossi, Laurence Albiges, Cyrus Chargari, Adrien Laville, Fabrice Barlesi, Eric Deutsch, Mansouria Merad, Enzo Battistella, Franck Griscelli, Arnaud Bayle, K. Ka, S. Achkar, Flore Salviat
Publikováno v:
International Journal of Radiation Oncology, Biology, Physics
PURPOSE: Patients with cancer are presumed to be more vulnerable to COVID-19. We evaluated a screening strategy combining chest computed tomography (CT) and reverse-transcription polymerase chain reaction (RT-PCR) for patients treated with radiation
Autor:
Jacob S Parzen, Steven L. Giannotta, Andrew Faramand, Matthew J. Shepard, Ajay Niranjan, Roman O. Kowalchuk, Eric L. Chang, Ahmet Atik, Inga S. Grills, Hsiu mei Wu, Gabriel Zada, Douglas Kondziolka, Jason Gurewitz, Ronald E. Warnick, Christopher P. Cifarelli, Khumar Guseynova, Daniel M. Trifiletti, Cheng-Chia Lee, Kenneth E. Bernstein, Roman Liscak, Azeem A. Rehman, Darrah Sheehan, David Mathieu, Herwin Speckter, Jason P. Sheehan, Joshua Bakhsheshian, Hideyuki Kano, L. Dade Lunsford, Kimball Sheehan
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 110:804-814
Purpose This study assesses a large multi-institutional database to present the outcomes of World Health Organization grade 2 meningiomas treated with stereotactic radiosurgery (SRS). We also compare the 3-year progression-free survival (PFS) to that
Autor:
Chae-Seon Hong, Jee Suk Chang, Jin Sung Kim, Hwa Kyung Byun, Nak Hoon Son, Ye-In Park, Namki Hong, Yong Bae Kim, Jihun Kim, Seo Hee Choi
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 110:462-472
To study the hypothyroidism risk after adjuvant radiation therapy (RT) and the association of different RT targets with hypothyroidism risk.We studied 4073 women treated with adjuvant RT for breast cancer from 2007 to 2016. The primary endpoint was h
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 110:444-451
Purpose Combined modality therapy (CMT) is standard therapy for early-stage Hodgkin lymphoma (ESHL). We previously reported excellent outcomes with the abbreviated Stanford V regimen. Herein we report updated results with median follow-up >10 years o
Autor:
Takenori Kato, Eisuke Tsukamoto, Kazuki Ishii, Kou Okada, Toshinori Hasegawa, Takafumi Tanei, Takehiro Naito
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 108:725-733
Vestibular schwannomas (VSs) are benign; thus, understanding long-term tumor control and late adverse radiation effects of stereotactic radiosurgery (SRS) through current radiosurgical techniques is important to inform treatment decisions. Our aim wa
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 106:985-992
Purpose The standard of care in management of patients with good performance status and unresectable stage III non-small cell lung cancer (NSCLC) therapy is concurrent chemoradiation. Newer techniques such as intensity modulated radiation therapy (IM
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 105:338-345
To determine whether the new American Joint Committee on Cancer (AJCC) 8 grouping of soft tissue sarcoma (STS) with nodal disease (N1M0) and metastatic disease (M1) as stage IV correctly represents the prognosis of these previously separate patient g
Autor:
Atif J. Khan, Salma K. Jabbour, Natalia Elsebai, Rahul R. Parikh, Sharad Goyal, Rihan Millevoi, Ning J. Yue, Apar Gupta, Bruce G. Haffty
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 104:714-723
Prior authorization (PA) has been widely implemented for proton beam therapy (PBT). We sought to determine the association between PA determination and patient characteristics, practice guidelines, and potential treatment delays.A single-institution
Autor:
Bryan S. Moon, Christina L. Roland, Alexander J. Lazar, Wei Lien Wang, Ravin Ratan, Keila E. Torres, B. Ashleigh Guadagnolo, Barry W. Feig, Andrew J. Bishop, Maria Alejandra Zarzour
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 103:1167-1174
To update our experience with long-term outcomes in patients with desmoid fibromatosis treated with radiation therapy (RT) and to characterize factors associated with increased risk of local recurrence.We reviewed the records of 209 consecutive patie